Treatment for Word Retrieval Impairments in Aphasia

The recruitment status of this study is unknown because the information has not been verified recently.

Verified May 2012 by Old Dominion University.
Recruitment status was Recruiting

Sponsor:

Collaborator:

National Institute on Deafness and Other Communication Disorders (NIDCD)

Information provided by (Responsible Party):

Dr. Anastasia Raymer, Old Dominion University

ClinicalTrials.gov Identifier:

NCT00764400

First received: September 30, 2008

Last updated: May 18, 2012

Last verified: May 2012

History of Changes

Purpose

In this study the investigators are examining the effectiveness of two different speech therapy protocols for word retrieval impairments experienced by individuals with stroke-induced aphasia. One treatment involves errorless naming treatment and the other employs verbal plus gestural facilitation of word retrieval. Participants will receive one of the two treatments over several months. Before and after treatment the investigators will administer several tests and conversational samples to examine changes associated with the treatments. The investigators hypothesize that, whereas both treatments will lead to improvements in words rehearsed in therapy, communication outcomes in conversation will be broader for the verbal plus gestural protocol.

Condition	Intervention	Phase
Stroke	Behavioral: Word Retrieval Treatments for Aphasia	Phase 1


Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Investigator) Primary Purpose: Treatment
Official Title:	Communication Outcomes for Naming Treatments in Aphasia

Resource links provided by NLM:

MedlinePlus related topics: Aphasia Speech and Communication Disorders

U.S. FDA Resources

Further study details as provided by Old Dominion University:

Primary Outcome Measures:

Daily Probe Picture Naming [ Time Frame: daily probes from three times per week for up to 3 months and one month posttreatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

Western Aphasia Battery [ Time Frame: pre-treatment and at treatment completion ] [ Designated as safety issue: No ]
Boston Naming Test [ Time Frame: pretreatment and at treatment completion ] [ Designated as safety issue: No ]
Discourse Sample [ Time Frame: pre-treatment and at treatment completion ] [ Designated as safety issue: No ]


Estimated Enrollment:	16
Study Start Date:	August 2008
Estimated Study Completion Date:	July 2012
Estimated Primary Completion Date:	June 2012 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Errorless Naming Treatment	Behavioral: Word Retrieval Treatments for Aphasia Speech therapy sessions take place 4 times per week for up to 90 minutes per session. Following a phase of baseline pre-testing, two phases of speech therapy will take place lasting up to 20 sessions per phase. Post-testing will take place immediately upon completion of the treatment phases and again at 1 month post study completion.
Experimental: Verbal+Gestural Facilitation	Behavioral: Word Retrieval Treatments for Aphasia Speech therapy sessions take place 4 times per week for up to 90 minutes per session. Following a phase of baseline pre-testing, two phases of speech therapy will take place lasting up to 20 sessions per phase. Post-testing will take place immediately upon completion of the treatment phases and again at 1 month post study completion.

Eligibility


Ages Eligible for Study:	21 Years to 90 Years (Adult, Senior)
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

left hemisphere stroke >4 months earlier
aphasia with word retrieval impairments
>21 years of age right handed
speaker of English as the preferred language
>6 grade education

Exclusion Criteria:

history of developmental learning difficulties
history of prior neurological illnesses
chronic medical illnesses that restrict participation in speech therapy
alcohol or drug dependence
severe uncorrected impairments of vision or hearing

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00764400

Contacts


Contact: Anastasia M Raymer, PhD	757-683-4522	sraymer@odu.edu
Contact: Sheryl Spence	757-683-4117

Locations


United States, Virginia
Old Dominion University Speech and Hearing Clinic	Recruiting
Norfolk, Virginia, United States, 23529
Contact: Anastasia M Raymer, PhD 757-683-4522 sraymer@odu.edu
Principal Investigator: Anastasia Raymer, PhD

Sponsors and Collaborators

Old Dominion University

National Institute on Deafness and Other Communication Disorders (NIDCD)

Investigators


Principal Investigator:	Anastasia M Raymer, PhD	Old Dominion University

More Information


Responsible Party:	Dr. Anastasia Raymer, Professor of Communications Disorders & Special Education, Old Dominion University
ClinicalTrials.gov Identifier:	NCT00764400 History of Changes
Other Study ID Numbers:	R15DC009690 3R15DC009690
Study First Received:	September 30, 2008
Last Updated:	May 18, 2012
Health Authority:	United States: Federal Government

Keywords provided by Old Dominion University:


aphasia anomia speech therapy rehabilitation

Additional relevant MeSH terms:


Aphasia Speech Disorders Language Disorders Communication Disorders	Neurobehavioral Manifestations Neurologic Manifestations Nervous System Diseases Signs and Symptoms

ClinicalTrials.gov processed this record on September 26, 2016

To Top